snmjournals.org

Preclinical Development of 3BP-3940, a Fibroblast Activation Protein–Targeted Cyclic Peptide–Based Radiotheranostic for Imaging and Therapy

Journal of Nuclear Medicine January 2026, jnumed.125.271452; DOI: https://doi.org/10.2967/jnumed.125.271452 ...
snmjournals.org

Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors

Journal of Nuclear Medicine November 2025, jnumed.125.270568; DOI: https://doi.org/10.2967/jnumed.125.270568 ...
snmjournals.org

CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction

Journal of Nuclear Medicine September 2025, jnumed.125.270807; DOI: https://doi.org/10.2967/jnumed.125.270807 ...
snmjournals.org

Prognostic Value of Comprehensive Analysis of Metastatic Prostate Tumor Changes from First to Last

Journal of Nuclear Medicine September 2025, jnumed.125.270358; DOI: https://doi.org/10.2967/jnumed.125.270358 ...
snmjournals.org

Lymphoma Therapy Response Assessment with Low-Dose

Journal of Nuclear Medicine August 2025, jnumed.124.268841; DOI: https://doi.org/10.2967/jnumed.124.268841 ...
snmjournals.org

A Prospective Provincial Registry of

Journal of Nuclear Medicine July 2025, jnumed.125.269653; DOI: https://doi.org/10.2967/jnumed.125.269653 ...
snmjournals.org

Efficacy, Safety, Blood Kinetics, and

Journal of Nuclear Medicine June 2025, jnumed.125.269655; DOI: https://doi.org/10.2967/jnumed.125.269655 ...
snmjournals.org

Approaches to Imaging Immune Activation Using PET

This review explores the role of PET in imaging immune activation, particularly in oncology. 18 F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...
snmjournals.org

Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study

Journal of Nuclear Medicine May 2025, jnumed.125.269533; DOI: https://doi.org/10.2967/jnumed.125.269533 ...
snmjournals.org

A Phase I/II Study of

Journal of Nuclear Medicine April 2025, jnumed.124.269064; DOI: https://doi.org/10.2967/jnumed.124.269064 ...
snmjournals.org

First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen–Targeted

Journal of Nuclear Medicine March 2025, jnumed.124.269299; DOI: https://doi.org/10.2967/jnumed.124.269299 ...
snmjournals.org

Preclinical Evaluation and Pilot Clinical Study of CD137 PET Radiotracer for Noninvasive Monitoring Early Responses of Immunotherapy

Given the variability in the effectiveness of immune checkpoint blocking therapy among patients and tumor types, development of noninvasive methods for longitudinal assessment of immune cell function ...